Portfolio Lab

ProShares UltraShort Health Care

  • ETF
  • Ticker RXD
  • NYSE

Performance, volatility and drawdowns of ProShares UltraShort Health Care since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

RXDGlobal equities (VT)

$10,000 grew to $860. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −93.0% in 11/2026, measured from the peak in 12/2016. The old peak has not been reached again yet.

Annual returns

Best year 2024 at +4.8%, weakest 2020 at −44.3%. 3 of 9 full years were positive. * partial year.

Similar ETFs

Frequently asked questions

How has RXD performed since 11/2016?

$10,000 grew to $860 by 20 Nov 2026, which is −21.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is RXD?

Volatility was 29.0% per year, measured on monthly returns. The largest decline from a peak was −93.0%, with the low in 11/2026.

How does RXD compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, RXD returned −21.8% at 29.0%. The correlation of monthly returns was -0.61; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

ProShares UltraShort Health Care (RXD): Return and risk